Nortis chip (now Quris-AI), fully functional at zero gravity.
Quris-AI Acquires Nortis
29. Oktober 2024 07:00 ET | Quris Technologies
BOSTON and TEL AVIV, Israel, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Quris-AI (Quris), a leading Bio-AI company focused on revolutionizing the pharmaceutical drug development process, today announced the...
blue-white.png
Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration
28. September 2023 08:00 ET | Quris Technologies
Merck KGaA and Quris-AI Expand Collaboration After a Successful Preclinical Study Assessed the Quris-AI BioAI Drug Safety Platform
Zion Market Research.jpg
Global Oxycodone Hydrochloride Market Size Scaling New Heights With $578.94 Million Projection by 2030, Showing a 4.66% CAGR
19. August 2023 19:00 ET | Zion Market Research
New York, NY, Aug. 19, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Oxycodone Hydrochloride Market By Type (Controlled-Release And Immediate-Release), By...
blue-white.png
Quris-AI Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023
02. März 2023 07:00 ET | Quris Technologies
BOSTON and TEL-AVIV, Israel, March 02, 2023 (GLOBE NEWSWIRE) -- Quris-AI, has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2023. This year’s...
blue-white.png
Quris Earns Additional Seed Investment Led by SoftBank Vision Fund 2
20. Dezember 2022 08:00 ET | Quris Technologies
BOSTON and TEL-AVIV, Israel, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has secured an additional $9...
Petrina Kamya, PhD, Head of AI Platforms at Insilico Medicine
Deepfake Technology in Drug Design
20. Oktober 2022 12:00 ET | InSilico Medicine
New York, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage artificial intelligence (AI)-driven drug discovery company, is utilizing the same deepfake technology used to create...
Walden Logo.png
Walden Biosciences Appoints Peter Guest Linde, M.D. as Chief Medical Officer
11. Oktober 2022 07:00 ET | Walden Biosciences, Inc.
CAMBRIDGE, Mass., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed biotechnology company focused on transforming the treatment of kidney disease, today...
Walden Logo.png
Walden Biosciences Announces Research Collaboration with University of Michigan
05. Juli 2022 09:00 ET | Walden Biosciences, Inc.
CAMBRIDGE, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed biotechnology company focused on transforming the treatment of kidney disease, today...
blue-white.png
Merck KGaA, Darmstadt, Germany, Enters into Option Agreement with Quris on its BioAI Platform for Clinical Safety Prediction
10. Februar 2022 00:00 ET | Quris Technologies
BOSTON and TEL-AVIV, Israel, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has signed an agreement with...
Pace corporate logo
Pace® Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services
11. Oktober 2021 07:45 ET | Pace Analytical
MINNEAPOLIS, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Pace Analytical Life Sciences®, LLC, a subsidiary of Pace Analytical® Services, LLC, a full-service contract development and manufacturing organization...